Evidence map›Paper›PMID 41033669›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Risk Factors Associated With Progression to Clinical Candida auris Infection Among Adults With Previous Colonization-Florida, 2019-2023.

Katharine E Saunders, Argentina Charles, Timothy J Doyle, Juliana Reyes, Gregory Champlin, Alina Corral, Jalysa Erskine, Ian Hennessee, Carina Blackmore

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Diabetes and Immunosuppression Drive Distinct Patterns ofbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katharine E SaundersEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-2886-6909
Argentina CharlesBureau of Epidemiology, Florida Department of Health, Tallahassee, Florida, USA.
Timothy J DoyleBureau of Epidemiology, Florida Department of Health, Tallahassee, Florida, USA.ORCID 0000-0002-4501-9157
Juliana ReyesBureau of Epidemiology, Florida Department of Health, Tallahassee, Florida, USA.
Gregory ChamplinBureau of Epidemiology, Florida Department of Health, Tallahassee, Florida, USA.
Alina CorralBureau of Epidemiology, Florida Department of Health, Tallahassee, Florida, USA.
Jalysa ErskineBureau of Epidemiology, Florida Department of Health, Tallahassee, Florida, USA.ORCID 0009-0009-4584-1683
Ian HennesseeMycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-8807-9566
Carina BlackmoreBureau of Epidemiology, Florida Department of Health, Tallahassee, Florida, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundCandida auris is an emerging fungal organism that has caused outbreaks in healthcare settings and become a major public health concern, particularly among medically vulnerable populations.

methodsUsing a retrospective case-control design, we investigated factors associated with C. auris clinical cases after prior colonization among patients identified in Florida healthcare facilities during 1 January 2019-31 December 2023.

resultsWe identified 105 case-patients with documented clinical specimens after colonization and 578 control subjects with colonization only. Factors significantly associated with clinical cases included presence of ≥5 comorbid conditions (odds ratio [OR], 10.02 [95% confidence interval {CI}, 4.07-24.7]), ≥ 4 invasive devices (OR, 2.92 [95% CI, 1.70-5.03]), or ≥3 recent medical procedures (OR, 2.32 [95% CI, 1.19-4.55]). In addition, fully dependent care required for eating (OR, 2.80), mobility (OR, 2.15), and transferring (OR, 1.82) were associated with clinical case progression.

conclusionsWe found a significant association with progression from screening colonization to clinical C. auris cases among patients with multiple comorbidities, invasive devices, recent invasive procedures, and poor functional status. Identifying risk factors for clinical progression of C. auris after colonization could enable facilities to implement efficient testing protocols and infection prevention and control measures to help prevent morbidity associated with invasive infections.

Indexed as

Candida aurisCandidiasisAdultAgedAged, 80 and overCandidaCandidiasis, InvasiveCase-Control StudiesDisease ProgressionFemaleFloridaHumansMaleMiddle AgedRetrospective StudiesRisk FactorsCandida auriscolonizationemerging fungal infectionshospital epidemiologyinfection prevention and control

Identifiers

PMID41033669
PMCPMC13094817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.